OPEN END TURBO CALL-OPTIONSSCHEIN MIT SL - ELI LILLY & CO | Market Closed - Boerse Frankfurt Warrants 03:47:48 2024-06-07 pm EDT | ||
| 56.37 EUR | +3.28% |
|
| Current month | +7.44% | ||
| 1 month | +13.74% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-07 | 56.72 | +3.92% |
| 24-06-06 | 54.58 | +0.37% |
| 24-06-05 | 54.38 | +0.30% |
| 24-06-04 | 54.22 | +0.65% |
| 24-06-03 | 53.87 | +2.05% |
Real-time Boerse Frankfurt Warrants
Last update June 07, 2024 at 03:47 pm EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Société Générale
|
| WKN | SD6KKT |
| ISIN | DE000SD6KKT9 |
| Date issued | 2021-06-08 |
| Strike | 241.7 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.96 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 56.72 € |
|---|---|
| Lowest since issue | 1.5 € |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
850
USD
Average target price
853.8
USD
Spread / Average Target
+0.44%
- Stock Market
- Certificates
- Certificat
